Amneal Pharmaceuticals, Inc.
AMRX
$10.83
$0.838.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.18% | -4.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.18% | -4.80% | |||
| Cost of Revenue | -0.23% | -5.82% | |||
| Gross Profit | 11.85% | -2.98% | |||
| SG&A Expenses | 5.05% | -8.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.03% | -8.75% | |||
| Operating Income | 10.99% | 27.76% | |||
| Income Before Tax | 37.95% | 344.70% | |||
| Income Tax Expenses | 25.12% | 137.29% | |||
| Earnings from Continuing Operations | 44.65% | 218.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -6.20% | -20.16% | |||
| Net Income | 83.82% | 139.24% | |||
| EBIT | 10.99% | 27.76% | |||
| EBITDA | 6.86% | 11.00% | |||
| EPS Basic | 82.40% | 139.08% | |||
| Normalized Basic EPS | 70.41% | 150.00% | |||
| EPS Diluted | 78.57% | 139.08% | |||
| Normalized Diluted EPS | 72.65% | 148.08% | |||
| Average Basic Shares Outstanding | 0.86% | 0.39% | |||
| Average Diluted Shares Outstanding | -0.49% | 4.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||